MedPath

Etco2 Levels on the End-tidal Concentration of Sevoflurane

Not Applicable
Completed
Conditions
End-tidal Carbon Dioxide
Minimum Alveolar Concentration
End-tidal Sevoflurane
Interventions
Procedure: low etco2
Procedure: high etco2
Procedure: normal etco2
Registration Number
NCT05778968
Lead Sponsor
Tanta University
Brief Summary

he assessment of adequate levels of anaesthesia traditionally relies not only on a patient's movement but also on the hemodynamic response (or both) to a surgical stimulus

Detailed Description

Currently a derivative of MAC namely, end tidal partial pressure (FET) displayed on the work station as concentration , maybe an alternative useful measure of the anaesthetic effect of an inhaled anaesthetic agent

. Many pharmacological factors have been associated with alterations in MAC and Mac derivatives such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and anesthetics.

However, few studies have focused on physiological factors, such as hypercarbia or hypocarbia. A correlation has been found between Paco2 and Etco2 in ventilated patients with healthy lungs. Some authors have suggested that Etco2 could be considered appropriate for estimating Paco2 even in critical patients. Knowledge of the effects of Paco2 on end tidal concentration of sevoflurane among patients undergoing laparoscopic cholecystectomy may help anaesthesiologists titrate sevoflurane carefully and precisely during different mechanical ventilation settings to avoid dose-dependent hypotension, impaired cardiac contractility, and hypothermia caused by excessive anaesthetic depth of sevoflurane.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • American Society of anaesthesiologist ASA physical status I, II
  • admitted for laparoscopic cholecystectomy
Exclusion Criteria
  • Refusal of patients.

    • Patients with renal or liver dysfunction.
    • Patients with chronic pain other than cholelithiasis.
    • Cardiac disorders as uncontrolled hypertension, arrhythmia, Ischaemic heart disease, valvular heart disease and pulmonary hypertension.
    • Patient with haematological disorder as Sickle cell disease.
    • Chest patient as asthma, COPD.
    • Combined surgery .
    • History of allergy to any of the study drugs.
    • Patients with communication problems, cognitive dysfunction, or psychological disorders.
    • Patients who received analgesics or sedatives 24 h before a scheduled surgery.
    • Alcohol or drug abuse.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
low ETCO2low etco2-
high ETCO2high etco2-
normal ETCO2normal etco2-
Primary Outcome Measures
NameTimeMethod
end tidal concentration of sevofluraneTotal time of operation

end tidal concentration of sevoflurane is measured by multiple gas analyser during operation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

tarek Abdelhay Mostafa

🇪🇬

Tanta, El Gharbyia, Egypt

© Copyright 2025. All Rights Reserved by MedPath